3,3-Dimethyl-1H-pyrrolo[3,2-g]quinolin-2(3H)-one derivatives as novel Raf kinase inhibitors

Chemical genetic discovery of targets and anti-targets for cancer polypharmacology

(2012) Arvin C. Dar et al.   NATURE

Emerging Raf inhibitors

(2009) James A McCubrey et al.   EXPERT OPINION ON EMERGING DRUGS

Selective Inhibitors of the Mutant B-Raf Pathway: Discovery of a Potent and Orally Bioavailable Aminoisoquinoline

(2009) Adrian L. Smith et al.   JOURNAL OF MEDICINAL CHEMISTRY

Targeted therapy for hepatocellular carcinoma

(2009) Hans Christian Spangenberg et al.   Nature Reviews Gastroenterology & Hepatology

Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway

(2009) Kwong-Kwok Wong   Recent Patents on Anti-Cancer Drug Discovery

Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas

(2008) Hui-Fang Li et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY